{
  "id": 4380,
  "text": "</td></tr></table></body></html> Sources: WHO, 2021 (11), WHO, 2021 $( 1 2 )$ .The full set of recommendations, along with relevant remarks, is provided in the guidance published in 2021 focused on the use of HPV DNA tests and the use of HPV mRNA tests (11, 12), and also in Annex 5 of this guideline.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: </td></tr></table></body></html> Sources: WHO, 2021 (11), WHO, 2021 $( 1 2 )$ .The full set of recommendations, along with relevant remarks, is provided in the guidance published in 2021 focused on the use of HPV DNA tests and the use of HPV mRNA tests (11, 12), and also in Annex 5 of this guideline.\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "对于宫颈癌筛查，HPV DNA 检测和 HPV mRNA 检测各有其应用建议。HPV DNA 检测被广泛推荐为首选的初筛方式，因为它能够检测到高危型 HPV 病毒的存在，预测癌前病变和宫颈癌的风险。而 HPV mRNA 检测则提供了关于病毒活动及致癌潜力的更多信息，是一种补充的方法，特别是在初筛检测结果不明确或需要进一步风险评估时使用。\n\n指导意见建议，在宫颈癌筛查方案中，对于30岁及以上的女性，首选进行 HPV DNA 检测。对于 HPV DNA 阳性但细胞学阴性的情况，HPV mRNA 检测可以作为后续评估的一种选项。此外，这些检测方法在结合细胞学检查时，可以提高筛查的灵敏度和特异性，从而更有效地预防和早期发现宫颈癌。",
  "query": "HPV DNA 检测与 HPV mRNA 检测在宫颈癌筛查中的具体建议是什么？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: HPV DNA 检测与 HPV mRNA 检测在宫颈癌筛查中的具体建议是什么？\n\n<reference text>: </td></tr></table></body></html> Sources: WHO, 2021 (11), WHO, 2021 $( 1 2 )$ .The full set of recommendations, along with relevant remarks, is provided in the guidance published in 2021 focused on the use of HPV DNA tests and the use of HPV mRNA tests (11, 12), and also in Annex 5 of this guideline.\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "对于宫颈癌筛查，HPV DNA 检测和 HPV mRNA 检测各有其应用建议。HPV DNA 检测被广泛推荐为首选的初筛方式，因为它能够检测到高危型 HPV 病毒的存在，预测癌前病变和宫颈癌的风险。而 HPV mRNA 检测则提供了关于病毒活动及致癌潜力的更多信息，是一种补充的方法，特别是在初筛检测结果不明确或需要进一步风险评估时使用。\n\n指导意见建议，在宫颈癌筛查方案中，对于30岁及以上的女性，首选进行 HPV DNA 检测。对于 HPV DNA 阳性但细胞学阴性的情况，HPV mRNA 检测可以作为后续评估的一种选项。此外，这些检测方法在结合细胞学检查时，可以提高筛查的灵敏度和特异性，从而更有效地预防和早期发现宫颈癌。"
}